Kathleen C Perry
Overview
Explore the profile of Kathleen C Perry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erali R, Pu T, Vu T, Mangieri C, Jee Y, Wise J, et al.
Am Surg
. 2023 May;
89(12):5842-5849.
PMID: 37183417
Background: Genetic testing is increasingly utilized in breast cancer patients; however, testing rates remain low. We aimed to evaluate the rate of genetic testing at a tertiary academic medical center...
2.
Valenzuela C, Moaven O, Solsky I, Stauffer J, Del Piccolo N, Cheung T, et al.
Ann Surg Oncol
. 2023 Mar;
30(6):3413-3422.
PMID: 36859704
Introduction: Complete resection of colorectal liver metastasis (CLM) improves long-term survival in colorectal cancer. However, there is limited recent data on conditional survival (CS) as postoperative survival milestones are achieved...
3.
Valenzuela C, Solsky I, Erali R, Forsythe S, Mangieri C, Mainali B, et al.
Ann Surg Oncol
. 2023 Feb;
30(5):2666-2675.
PMID: 36754945
Background: Malignant peritoneal mesothelioma (MPM) is a rare diagnosis with a dismal prognosis if untreated. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is shown to significantly improve survival. Our institution...
4.
Valenzuela C, Moaven O, Gawdi R, Stauffer J, Del Piccolo N, Cheung T, et al.
J Surg Oncol
. 2022 Aug;
126(7):1242-1252.
PMID: 35969175
Background: Resection of colorectal liver metastasis (CLM) is beneficial when feasible. However, the benefit of second hepatectomy for hepatic recurrence in CLM remains unclear. Methods: The Colorectal Liver Operative Metastasis...
5.
Lundy M, Moaven O, Perry K, Mangieri C, Valenzuela C, Russell G, et al.
J Am Coll Surg
. 2022 Mar;
234(4):546-556.
PMID: 35290274
Background: Cytoreductive surgery (CRS) is at the forefront of treatment for colorectal cancer with peritoneal metastasis or "carcinomatosis" (CRC-PC). We report outcomes of the operative management of CRC-PC at a...
6.
Valenzuela C, Moaven O, Gawdi R, Stauffer J, Del Piccolo N, Cheung T, et al.
HPB (Oxford)
. 2022 Mar;
24(8):1351-1361.
PMID: 35289279
Background: Primary laterality of colorectal cancer is thought to be associated with differences in outcomes. Liver metastasis is the most common site of solitary colorectal cancer spread. However, how primary...
7.
Valenzuela C, Levine E, Mangieri C, Gawdi R, Moaven O, Russell G, et al.
Ann Surg Oncol
. 2022 Mar;
29(6):3436-3445.
PMID: 35286531
Background: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) improves survival in abdominal cancer patients with metastatic disease limited to the peritoneal cavity. Patients are increasingly being offered repeat CRS-HIPECs for...
8.
Valenzuela C, Mangieri C, Garland-Kledzik M, Gawdi R, Russell G, Perry K, et al.
Ann Surg Oncol
. 2022 Mar;
29(6):3422-3431.
PMID: 35254575
Background: Low-grade appendiceal mucinous neoplasm (LAMN) with peritoneal involvement is a common indication for cytoreductive surgery with heated intraperitoneal chemotherapy (CRS/HIPEC). With peritoneal recurrence, patients are increasingly being offered repeat...
9.
Moaven O, Su J, Jin G, Votanopoulos K, Shen P, Mangieri C, et al.
Ann Surg Oncol
. 2020 Jul;
27(13):5016-5023.
PMID: 32705511
Introduction: Clinical decision-making is challenging in patients who undergo cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) when complete cytoreduction is not feasible. Nevertheless, some patients still benefit with long-term survival after incomplete...
10.
Duckworth K, McQuellon R, Russell G, Perry K, Nightingale C, Shen P, et al.
J Am Coll Surg
. 2020 Feb;
230(4):679-687.
PMID: 32007532
Background: Cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy (CRS+HIPEC) is a formidable procedure, often affecting the quality of life (QOL) of the caregiver as well as the patient. We explored the...